Tags | Domains | Searches | Statistics | Options | Advanced Search
|
Tags | Domains | Searches | Statistics | Options | Advanced Search |
Know More Media - Management / Operations - Dec 6, 2007
Just hours before a scheduled meeting with analysts and investors, Bristol-Myers Squibb Co. (BMY) announced they will be laying off about 10 percent of its workforce through the closing down of up to half of its …
Also tagged: cancer, diabetes, pharmaceutical, bmy, job cuts, business trends, bristol myers, closing factory, drug patents, patent expirations
ManagersRealm - Dec 6, 2007
Just hours before a scheduled meeting with analysts and investors, Bristol-Myers Squibb Co. (BMY) announced they will be laying off about 10 percent of its workforce through the closing down of up to half of its …
Also tagged: cancer, diabetes, pharmaceutical, bmy, job cuts, business trends, bristol myers
Know More Media - International Business - Nov 12, 2007
Sales of generic drugs in Japan jumped 13% so far this year over last year to Y350 billion ($3.2 billion). Prices for drugs were down, thanks to the government revising costs, but sales volume was up. Still, those …
Also tagged: japan, market share, doing business in japan
RisingSunofNihon - Nov 12, 2007
Sales of generic drugs in Japan jumped 13% so far this year over last year to Y350 billion ($3.2 billion). Prices for drugs were down, thanks to the government revising costs, but sales volume was up. Still, those …
Also tagged: japan, market share, doing business in japan
Know More Media - Health Care / Pharmaceutical / Fitness - Oct 10, 2007
Glenmark Pharmaceuticals Limited (NSE:GLENMARK)has received final U.S. Food and Drug Administration approval to market generic Trileptal (Oxcarbazepine) tablets. Trileptal is currently manufactured by Roxane …
Also tagged: epilepsy, trileptal, seizures, drug regulations and approval, glenmark
PharmaGazette - Oct 10, 2007
Glenmark Pharmaceuticals Limited (NSE:GLENMARK)has received final U.S. Food and Drug Administration approval to market generic Trileptal (Oxcarbazepine) tablets. Trileptal is currently manufactured by Roxane …
Also tagged: epilepsy, trileptal, seizures, drug regulations and approval
PharmaGazette - Sep 28, 2007
WalMart Store Inc. (NADSAQ: WMT) announced the launch of the second phase of their $4 prescription drug program. Phase 2 offers more medicines in more categories like attention deficit disorder, glaucoma, fungal …
Also tagged: wmt, news and events, walmart, prescription drugs
Know More Media - Health Care / Pharmaceutical / Fitness - Sep 28, 2007
WalMart Store Inc. (NADSAQ: WMT) announced the launch of the second phase of their $4 prescription drug program. Phase 2 offers more medicines in more categories like attention deficit disorder, glaucoma, fungal …
Also tagged: wmt, news and events, walmart, prescription drugs
Know More Media - Health Care / Pharmaceutical / Fitness - Sep 21, 2007
An article today in The New York Times, by Stephanie Saul, debates different reasons for the slowing of inflation in drugs cost. One of the aspects she discusses is "the WalMart effect" which is the initiative that …
Also tagged: walmart, drug marketing, drug costs
PharmaGazette - Sep 21, 2007
An article today in The New York Times, by Stephanie Saul, debates different reasons for the slowing of inflation in drugs cost. One of the aspects she discusses is "the WalMart effect" which is the initiative that …
Also tagged: walmart, drug marketing, drug costs